Spero Therapeutics, Inc. (SPRO) News
Follow Spero Therapeutics, Inc. (SPRO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Spero Therapeutics announces Nasdaq inducement grant under Rule 5635(c)(4)
Spero Therapeutics announced an inducement grant under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 03, 2026, 08:08 PM UTC
L
Spero Therapeutics board compensation committee approves inducement grant
Spero Therapeutics says its Compensation Committee approved an inducement grant under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 03, 2026, 08:08 PM UTC
L
SPRO - Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
SPRO - Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 02, 2026, 08:01 PM UTC
M
Spero Therapeutics launches $100M ATM program with Jefferies
Spero Therapeutics has launched a new at-the-market (ATM) program with Jefferies for up to $100 million.
EQUITY | Aug 28, 2026, 09:35 PM UTC
L
Spero Therapeutics may offer up to $300 million in securities
Spero Therapeutics filed with the SEC, saying it may offer up to $300 million in securities.
REGULATION | Aug 28, 2026, 09:09 PM UTC
L
SPRO Announces Q2 2026 Operating Results
Spero Therapeutics announces second quarter 2026 operating results and provides business update
EARNINGS | Aug 12, 2026, 08:01 PM UTC
L
SPRO - Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
SPRO - Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
EARNINGS | Aug 04, 2026, 08:01 PM UTC
H
Sector Update: Healthcare Stocks Mixed Premarket Tuesday
() -- Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.3% and the iShares Biotechnology ETF (IBB) 0.1% higher. HCA Healthcare (HCA) shares were down mo
EARNINGS | Jul 14, 2026, 01:16 PM UTC
L
SPRO IVBIY innovent Biologics and Spero Therapeutics announce exclusive license for ibi355 (sp001), a phase 2-ready third-generation anti-cd
SPRO IVBIY innovent Biologics and Spero Therapeutics announce exclusive license for ibi355 (sp001), a phase 2-ready third-generation anti-cd40l antibody Innovent Biologics - Spero receives exclusive global rights to ibi3
GEOPOLITICS | Jul 14, 2026, 10:26 AM UTC
H
Spero Therapeutics Announces $105M In Non-Recourse Non-Dilutive Royalty Financing With KKR's Healthcare Royalty
Financing supports Phase 2 development of SP001, Spero’s first immunology drug candidate, in-licensed from Innovent Biologics Transaction unlocks immediate value from future Utebzi (tebipenem pivoxil) milestones and roya
EARNINGS | Jul 14, 2026, 10:11 AM UTC